Evidence map›Paper›PMID 28192532›Full record

ArticlePLoS pathogens2017

Role of Arf GTPases in fungal morphogenesis and virulence.

Hayet Labbaoui, Stéphanie Bogliolo, Vikram Ghugtyal, Norma V Solis, Scott G Filler, Robert A Arkowitz, Martine Bassilana

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. The mRNA stability factor Khd4 defines a specific mRNA regulon for membrane trafficking in the pathogenProceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  6. Article
  7. Article
  8. Lipid Transport byInfection and immunity · 2022
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Overexpression ofSmall GTPases · 2020
    Article
  15. Changes in the Ultrastructure ofMicroorganisms · 2020
    Article
  16. The Role of Secretory Pathways inJournal of fungi (Basel, Switzerland) · 2020
    Review
  17. Candida albicansmBio · 2019
    Article
  18. Article
  19. Review
  20. Role of lipid transporters in fungal physiology and pathogenicity.Computational and structural biotechnology journal · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Hayet LabbaouiUniversité Côte d'Azur, CNRS, INSERM, iBV, Parc Valrose, Nice, France.
Stéphanie BoglioloUniversité Côte d'Azur, CNRS, INSERM, iBV, Parc Valrose, Nice, France.
Vikram GhugtyalUniversité Côte d'Azur, CNRS, INSERM, iBV, Parc Valrose, Nice, France.
Norma V SolisLos Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, United States of America.
Scott G FillerLos Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, United States of America.ORCID 0000-0001-7278-3700
Robert A ArkowitzUniversité Côte d'Azur, CNRS, INSERM, iBV, Parc Valrose, Nice, France.ORCID 0000-0002-5216-5013
Martine BassilanaUniversité Côte d'Azur, CNRS, INSERM, iBV, Parc Valrose, Nice, France.ORCID 0000-0001-9965-567X
Centre National de la Recherche Scientifique · FRThe Lundquist Institute · US

Funding

Candida albicans Epithelial Cell Interactions and Oropharyngeal DiseaseR01DE017088 · NIDCR · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI FILLER, SCOTT G · 2005 to 2014
$3.4M
C. albicans invasion and proliferation during oral infectionR01DE026600 · NIDCR · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI FILLER, SCOTT G, MITCHELL, AARON P · 2017 to 2021
$3.0M
Endothelial invasion by yeast-phase CandidaR01AI124566 · NIAID · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI FILLER, SCOTT G, MITCHELL, AARON P · 2016 to 2020
$2.7M
NIAID NIH HHS R01 AI124566NIDCR NIH HHS R01 DE017088NIDCR NIH HHS R01 DE026600
6 · The paper itself

Abstract

Virulence of the human fungal pathogen Candida albicans depends on the switch from budding to filamentous growth, which requires sustained membrane traffic and polarized growth. In many organisms, small GTPases of the Arf (ADP-ribosylation factor) family regulate membrane/protein trafficking, yet little is known about their role in fungal filamentous growth. To investigate these GTPases in C. albicans, we generated loss of function mutants in all 3 Arf proteins, Arf1-Arf3, and 2 Arf-like proteins, Arl1 and Arl3. Our results indicate that of these proteins, Arf2 is required for viability and sensitivity to antifungal drugs. Repressible ARF2 expression results in defects in filamentous growth, cell wall integrity and virulence, likely due to alteration of the Golgi. Arl1 is also required for invasive filamentous growth and, although arl1/arl1 cells can initiate hyphal growth, hyphae are substantially shorter than that of the wild-type, due to the inability of this mutant to maintain hyphal growth at a single site. We show that this defect does not result from an alteration of phospholipid distribution and is unlikely to result from the sole Golgin Imh1 mislocalization, as Imh1 is not required for invasive filamentous growth. Rather, our results suggest that the arl1/arl1 hyphal growth defect results from increased secretion in this mutant. Strikingly, the arl1/arl1 mutant is drastically reduced in virulence during oropharyngeal candidiasis. Together, our results highlight the importance of Arl1 and Arf2 as key regulators of hyphal growth and virulence in C. albicans and identify a unique function of Arl1 in secretion.

Indexed as

ADP-Ribosylation FactorsAnimalsBlotting, WesternCandida albicansCandidiasisDisease Models, AnimalFungal ProteinsGene Knockout TechniquesMembrane ProteinsMiceMice, Inbred BALB CMorphogenesisVirulenceADP-ribosylation factor related proteinsADP-Ribosylation FactorsFungal ProteinsMembrane Proteins

Identifiers

PMID28192532
PMCPMC5325608
OpenAlexW2588978232

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.